During this presentation we will discuss various ‘hot topics’ in buprenorphine treatment for opioid use disorder. We will discuss the trends in treatment strategies in both addiction and non-addiction health care environments. We will discuss new formulations of buprenorphine, including new injectable formulations. “Clinical case conundrums” will be presented for discussion. Ample time will be available for questions. After participating in this program, participants will be able to:

After attending this program, participants will be able to:

(1) Trace buprenorphine treatment for opioid use disorders has evolved in the U.S. and discuss new formulations of buprenorphine, including injectable forms that are being used to enhance access to opioid use disorder medication treatment; and,

(2) Discuss new means to initiate or maintain buprenorphine care, including practices such as low dose buprenorphine initiation (LDBI) and maintenance of buprenorphine I the perioperative period.